D.S. Chi

1.8k total citations · 1 hit paper
43 papers, 1.3k citations indexed

About

D.S. Chi is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, D.S. Chi has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Reproductive Medicine, 18 papers in Surgery and 16 papers in Obstetrics and Gynecology. Recurrent topics in D.S. Chi's work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (16 papers) and Intraperitoneal and Appendiceal Malignancies (11 papers). D.S. Chi is often cited by papers focused on Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (16 papers) and Intraperitoneal and Appendiceal Malignancies (11 papers). D.S. Chi collaborates with scholars based in United States, Germany and Denmark. D.S. Chi's co-authors include R.R. Barakat, Nadeem R. Abu‐Rustum, Jae Huh, Yukio Sonoda, Martee L. Hensley, Douglas A. Levine, J. Lang, Lisa B. Haddad, Eric Eisenhauer and Mario M. Leitão and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Gastroenterology.

In The Last Decade

D.S. Chi

42 papers receiving 1.3k citations

Hit Papers

What is the optimal goal of primary cytoreductive surgery... 2006 2026 2012 2019 2006 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    2006 465 citations D.S. Chi, Eric Eisenhauer et al. Gynecologic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.S. Chi United States 15 883 633 594 201 175 43 1.3k
Moni Roy United States 13 424 0.5× 318 0.5× 246 0.4× 204 1.0× 224 1.3× 52 995
Hiroyuki Ochi Japan 18 227 0.3× 214 0.3× 209 0.4× 375 1.9× 166 0.9× 43 974
Marleen Bakker Netherlands 17 69 0.1× 123 0.2× 198 0.3× 263 1.3× 153 0.9× 34 757
Angus McIndoe United Kingdom 17 218 0.2× 370 0.6× 148 0.2× 109 0.5× 43 0.2× 21 865
Mamiko Onuki Japan 16 142 0.2× 155 0.2× 176 0.3× 292 1.5× 128 0.7× 36 708
James Nevin United Kingdom 16 154 0.2× 129 0.2× 461 0.8× 167 0.8× 268 1.5× 42 774
Neelam B. Kumar United States 10 82 0.1× 154 0.2× 184 0.3× 277 1.4× 176 1.0× 11 638
S. Thoresen Norway 14 100 0.1× 240 0.4× 246 0.4× 613 3.0× 300 1.7× 21 939
G Foglia Italy 9 170 0.2× 64 0.1× 205 0.3× 185 0.9× 84 0.5× 15 573
O Rotimi United Kingdom 10 116 0.1× 89 0.1× 226 0.4× 40 0.2× 61 0.3× 22 434

Countries citing papers authored by D.S. Chi

Since Specialization
Citations

This map shows the geographic impact of D.S. Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.S. Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.S. Chi more than expected).

Fields of papers citing papers by D.S. Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.S. Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.S. Chi. The network helps show where D.S. Chi may publish in the future.

Co-authorship network of co-authors of D.S. Chi

This figure shows the co-authorship network connecting the top 25 collaborators of D.S. Chi. A scholar is included among the top collaborators of D.S. Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.S. Chi. D.S. Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Lixia, D.S. Chi, Chao Zhen, et al.. (2025). Clinical performance validation of an integrated cartridge based bedside blood gas analyzer system in the acute care setting. Scientific Reports. 15(1). 20620–20620.
2.
Byrne, Maureen, Richard Cowan, Kara Long Roche, et al.. (2018). Preoperative factors associated with unsuccessful palliation following surgery for malignant bowel obstruction in patients with recurrent ovarian cancer. Gynecologic Oncology. 149. 224–224. 2 indexed citations
3.
Oseledchyk, Anton, Mario M. Leitão, Jason Konner, et al.. (2017). Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000–2013. Annals of Oncology. 28(12). 2985–2993. 56 indexed citations
4.
Zivanovic, Oliver, Mario M. Leitão, Yukio Sonoda, et al.. (2016). Risk prediction model for surgical site infections in patients undergoing gynecologic cancer surgery. Gynecologic Oncology. 141. 166–166. 1 indexed citations
5.
Mahner, Sven�, Fabian Trillsch, D.S. Chi, et al.. (2016). Neoadjuvant chemotherapy in ovarian cancer revisited. Annals of Oncology. 27. i30–i32. 16 indexed citations
6.
Suidan, R.S., Pedro T. Ramírez, Douglas A. Levine, et al.. (2015). A multicenter prospective assessment of surgical findings associated with suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube and peritoneal cancer. Gynecologic Oncology. 137. 40–40. 1 indexed citations
7.
Barlin, Joyce N., K. Long, Edward J. Tanner, et al.. (2013). Optimal (≤1cm) but visible residual disease: Is extensive debulking warranted?. Gynecologic Oncology. 130(2). 284–288. 19 indexed citations
8.
Barber, Emma L., Fady Khoury‐Collado, Joyce N. Barlin, et al.. (2013). Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Gynecologic Oncology. 130(1). e73–e73. 25 indexed citations
9.
Kim, Christine H., Nadeem R. Abu‐Rustum, D.S. Chi, et al.. (2012). Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer. Gynecologic Oncology. 125(3). 585–588. 82 indexed citations
10.
Andikyan, Vaagn, Fady Khoury‐Collado, Scott R. Gerst, et al.. (2012). Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: Review of surgical technique, complications, and outcome. Gynecologic Oncology. 126(3). 346–350. 14 indexed citations
11.
12.
Shih, Karin, Eun Young Yun, Ginger J. Gardner, et al.. (2011). Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecologic Oncology. 122(3). 608–611. 44 indexed citations
13.
Shih, Karin, Qin Zhou, Jae Huh, et al.. (2010). Risk factors for recurrence of ovarian borderline tumors. Gynecologic Oncology. 120(3). 480–484. 80 indexed citations
14.
Shih, Karin, D.S. Chi, R.R. Barakat, & Mario M. Leitão. (2010). Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series. Gynecologic Oncology. 117(2). 330–335. 38 indexed citations
15.
Shih, Karin, D.S. Chi, R.R. Barakat, & Mario M. Leitão. (2009). Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Gynecologic Oncology. 116(3). 364–369. 27 indexed citations
16.
Sonoda, Yukio, et al.. (2007). Initial experience with Dargent's operation: The radical vaginal trachelectomy. Gynecologic Oncology. 108(1). 214–219. 66 indexed citations
17.
Chi, D.S., Eric Eisenhauer, J. Lang, et al.. (2006). What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecologic Oncology. 103(2). 559–564. 465 indexed citations breakdown →
18.
Gemignani, Mary L., et al.. (1999). Splenectomy in Recurrent Epithelial Ovarian Cancer. Gynecologic Oncology. 72(3). 407–410. 49 indexed citations
19.
Chi, D.S., Borys Mychalczak, Patricia E. Saigo, John Rescigno, & Carol L. Brown. (1997). The Role of Whole-Pelvic Irradiation in the Treatment of Early-Stage Uterine Carcinosarcoma. Gynecologic Oncology. 65(3). 493–498. 67 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moni Roy Breakdown of academic impact, for papers by Hiroyuki Ochi Breakdown of academic impact, for papers by Marleen Bakker Breakdown of academic impact, for papers by Angus McIndoe Breakdown of academic impact, for papers by Mamiko Onuki Breakdown of academic impact, for papers by James Nevin Breakdown of academic impact, for papers by Neelam B. Kumar Breakdown of academic impact, for papers by S. Thoresen Breakdown of academic impact, for papers by G Foglia Breakdown of academic impact, for papers by O Rotimi
Rankless by CCL
2026